Genotype-guided dosing of warfarin

Clin Chem. 2014 Jul;60(7):920-2. doi: 10.1373/clinchem.2013.220004. Epub 2014 Apr 1.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anticoagulants / agonists*
  • Aryl Hydrocarbon Hydroxylases / genetics
  • Atrial Fibrillation / blood
  • Atrial Fibrillation / drug therapy
  • Clinical Trials as Topic
  • Cytochrome P-450 CYP2C9
  • Drug Monitoring
  • Genotype
  • Humans
  • International Normalized Ratio
  • Venous Thromboembolism / blood
  • Venous Thromboembolism / drug therapy
  • Vitamin K Epoxide Reductases / genetics
  • Warfarin / administration & dosage*

Substances

  • Anticoagulants
  • Warfarin
  • CYP2C9 protein, human
  • Cytochrome P-450 CYP2C9
  • Aryl Hydrocarbon Hydroxylases
  • VKORC1 protein, human
  • Vitamin K Epoxide Reductases